Abstract: A new compound composition that is free of a side effect to a liver and used for alleviating the toxicity of an acetaminophen (APAP) medicament to the liver. The compound composition comprises (a) a pharmaceutically effective amount of acetaminophen and (b) a frequently-used safe and pharmaceutically acceptable excipient that can be combined with one or more than two medicaments that can reduce the toxicity of a drug via liver enzyme CYP2E1 metabolism to the liver.
Type:
Application
Filed:
November 23, 2022
Publication date:
March 16, 2023
Applicant:
NATIONAL DEFENSE EDUCATION AND RESEARCH FOUNDATION
Abstract: A new compound composition that is free of a side effect to a liver and used for alleviating the toxicity of an acetaminophen (APAP) medicament to the liver. The compound composition comprises (a) a pharmaceutically effective amount of acetaminophen and (b) a frequently-used safe and pharmaceutically acceptable excipient that can be combined with one or more than two medicaments that can reduce the toxicity of a drug via liver enzyme CYP2E1 metabolism to the liver.
Type:
Grant
Filed:
May 14, 2019
Date of Patent:
December 27, 2022
Assignee:
NATIONAL DEFENSE EDUCATION AND RESEARCH FOUNDATION
Abstract: A new compound composition that is free of a side effect to a liver and used for alleviating the toxicity of an acetaminophen (APAP) medicament to the liver. The compound composition comprises (a) a pharmaceutically effective amount of acetaminophen and (b) a frequently-used safe and pharmaceutically acceptable excipient that can be combined with one or more than two medicaments that can reduce the toxicity of a drug via liver enzyme CYP2E1 metabolism to the liver.
Type:
Grant
Filed:
November 13, 2013
Date of Patent:
September 24, 2019
Assignee:
NATIONAL DEFENSE EDUCATION AND RESEARCH FOUNDATION
Abstract: A new compound composition that is free of a side effect to a liver and used for alleviating the toxicity of an acetaminophen (APAP) medicament to the liver. The compound composition comprises (a) a pharmaceutically effective amount of acetaminophen and (b) a frequently-used safe and pharmaceutically acceptable excipient that can be combined with one or more than two medicaments that can reduce the toxicity of a drug via liver enzyme CYP2E1 metabolism to the liver.
Type:
Application
Filed:
May 14, 2019
Publication date:
August 29, 2019
Applicant:
NATIONAL DEFENSE EDUCATION AND RESEARCH FOUNDATION
Abstract: The present invention relates to a composition and method for preventing or treating fatty pancreas, or ameliorating a pancreas disease caused by fatty pancreas, diabetes mellitus or other related disorders.
Type:
Application
Filed:
November 21, 2016
Publication date:
November 15, 2018
Applicant:
NATIONAL DEFENSE EDUCATION AND RESEARCH FOUNDATION
Inventors:
Oliver Yoa-Pu HU, Hsin-Tien HO, Yung-En WU, Hsi-Hui TANG
Abstract: A new compound composition that is free of a side effect to a liver and used for alleviating the toxicity of an acetaminophen (APAP) medicament to the liver. The compound composition comprises (a) a pharmaceutically effective amount of acetaminophen and (b) a frequently-used safe and pharmaceutically acceptable excipient that can be combined with one or more than two medicaments that can reduce the toxicity of a drug via liver enzyme CYP2E1 metabolism to the liver.
Type:
Application
Filed:
November 13, 2013
Publication date:
June 22, 2017
Applicant:
NATIONAL DEFENSE EDUCATION AND RESEARCH FOUNDATION
Abstract: A pharmaceutical composition for treating tuberculotic diseases with no side effect/low side effect is provided by the present invention, which pharmaceutically effective amount of one or more compounds chosen from isoniazid, rifampin, pyrazinamide and ethambutol, and pharmaceutically effective amount of substances which can reduce the side effect of the antituberculosis agents.
Type:
Grant
Filed:
April 20, 2011
Date of Patent:
March 3, 2015
Assignee:
National Defense Education and Research Foundation
Inventors:
Oliver Yaopu Hu, Tonho Young, Chenghuei Hsiong, Wenliang Chang, Tungyuan Shih, Hsintien Ho
Abstract: A pharmaceutical composition for treating tuberculotic diseases with no side effect/low side effect is provided by the present invention, which pharmaceutically effective amount of one or more compounds chosen from isoniazid, rifampin, pyrazinamide and ethambutol, and pharmaceutically effective amount of substances which can reduce the side effect of the antituberculosis agents.
Type:
Application
Filed:
April 20, 2011
Publication date:
February 6, 2014
Applicant:
NATIONAL DEFENSE EDUCATION AND RESEARCH FOUNDATION
Inventors:
Oliver Yaopu Hu, Tonho Young, Chenghuei Hsiong, Wenliang Chang, Tungyuan Shih, Hsintien Ho
Abstract: The present invention features a novel, low side-effect pharmaceutical compound complex, comprising the pharmaceutically effective dose of isoniazid (INH) and pharmaceutically effective dose of one of the following compounds.
Type:
Grant
Filed:
July 23, 2008
Date of Patent:
November 6, 2012
Assignee:
National Defense Education and Research Foundation